Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Factors Affecting Renal Clearance: Renal Impairment01:17

Factors Affecting Renal Clearance: Renal Impairment

534
Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
534
Determination of Renal Drug Clearance: Graphical and Midpoint Methods01:07

Determination of Renal Drug Clearance: Graphical and Midpoint Methods

454
Renal clearance, a crucial parameter in pharmacokinetics, can be determined using two different methods: the graphical method and the midpoint method. These methods provide insights into the rate of drug excretion by the kidneys and aid in assessing renal function.
The graphical method involves plotting the rate of drug excretion in urine against the plasma drug concentration. By analyzing the graph, the clearance can be calculated and obtained. Drugs rapidly excreted by the kidneys exhibit a...
454
Acute Kidney Injury III: Clinical Manifestations01:29

Acute Kidney Injury III: Clinical Manifestations

1.2K
Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
1.2K
Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration01:28

Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration

285
Glomerular filtration rate (GFR) can be estimated from serum creatinine using the modification of diet in renal disease (MDRD) formula or the chronic kidney disease–epidemiology collaboration (CKD–EPI) equation. Both methods are widely used in clinical practice to assess kidney function and guide treatment decisions.The MDRD equation does not require weight or height measurements and is normalized to the body surface area of 1.73 m², considered the average adult surface area.
285
Acute Kidney Injury I: Introduction01:22

Acute Kidney Injury I: Introduction

1.0K
Introduction:Acute Kidney Injury (AKI) describes a swift decrease in kidney function occurring over hours to days, characterized by the kidneys' failure to remove waste products from the bloodstream. This leads to dangerous complications like metabolic acidosis, fluid overload, and electrolyte imbalances, such as hyperkalemia, which can cause life-threatening arrhythmias. AKI is common in both hospital and outpatient settings, often triggered by dehydration, sepsis, or exposure to nephrotoxic...
1.0K
Serum Studies: Renal Function Tests01:24

Serum Studies: Renal Function Tests

564
Renal function tests are crucial for assessing kidney health, monitoring disease progression, and evaluating the kidneys' efficiency in waste elimination, fluid balance, and electrolyte regulation. These tests offer critical insights into kidney function, even though routine measurements may appear normal until there is a significant decline in the glomerular filtration rate or GFR. Typically, signs of kidney impairment only become evident when the GFR falls to about 50% of its normal level.
564

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Depressive symptoms in chronic kidney disease: the hidden role of uremic toxins.

BMJ mental health·2026
Same author

Drug prescription for patients treated by dialysis: navigation in the fog.

Clinical kidney journal·2026
Same author

Cognitive Impairment Predicts Adverse Outcomes in CKD.

Kidney international reports·2026
Same author

French nephrologists’ practices in the management of anemia and iron deficiency in chronic kidney disease

Nephrologie & therapeutique·2026
Same author

Drug prescription before and after dialysis initiation in older patients: a nationwide study.

BMC geriatrics·2026
Same author

Optimal patient care in advanced chronic kidney disease progressing to kidney failure.

Nature reviews. Nephrology·2026

Related Experiment Video

Updated: Mar 9, 2026

Application of Laser Microdissection to Uncover Regional Transcriptomics in Human Kidney Tissue
05:46

Application of Laser Microdissection to Uncover Regional Transcriptomics in Human Kidney Tissue

Published on: June 9, 2020

4.4K

Identifying subgroups of renal function trajectories.

Julie Boucquemont1, Lucie Loubère1, Marie Metzger2

  • 1Univ. Bordeaux, ISPED, Centre INSERM U1219-Bordeaux Population Health Research, Bordeaux, France.

Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association
|December 30, 2016
PubMed
Summary
This summary is machine-generated.

Latent class linear mixed modeling identified five distinct chronic kidney disease (CKD) patient subgroups based on renal function trajectories. This approach helps characterize CKD progression and associated risk factors.

Keywords:
chronic kidney disease progressiongrowth mixture modellinglatent class linear mixed modelmeasured glomerular filtration ratetrajectories

More Related Videos

Microdissection of Primary Renal Tissue Segments and Incorporation with Novel Scaffold-free Construct Technology
09:00

Microdissection of Primary Renal Tissue Segments and Incorporation with Novel Scaffold-free Construct Technology

Published on: March 27, 2018

8.0K

Related Experiment Videos

Last Updated: Mar 9, 2026

Application of Laser Microdissection to Uncover Regional Transcriptomics in Human Kidney Tissue
05:46

Application of Laser Microdissection to Uncover Regional Transcriptomics in Human Kidney Tissue

Published on: June 9, 2020

4.4K
Microdissection of Primary Renal Tissue Segments and Incorporation with Novel Scaffold-free Construct Technology
09:00

Microdissection of Primary Renal Tissue Segments and Incorporation with Novel Scaffold-free Construct Technology

Published on: March 27, 2018

8.0K

Area of Science:

  • Nephrology
  • Biostatistics
  • Chronic Kidney Disease Research

Background:

  • Chronic kidney disease (CKD) patient renal function can exhibit diverse progression patterns.
  • Understanding these trajectories is crucial for personalized patient management and treatment strategies.

Purpose of the Study:

  • To evaluate the efficacy of latent class linear mixed modeling (LCMM) in identifying distinct renal function trajectory subgroups within a CKD cohort.
  • To illustrate the clinical relevance of identified subgroups in a multicenter hospital-based CKD patient population.

Main Methods:

  • Analysis of the NephroTest cohort data, including 1967 CKD patients with baseline glomerular filtration rate (GFR) measurements.
  • Utilized LCMM to identify subgroups of GFR trajectories, comparing baseline patient characteristics across identified subgroups.
  • Employed both measured GFR (mGFR) via 51Cr-EDTA renal clearance and estimated GFR (eGFR) using the CKD-EPI equation.

Main Results:

  • Five distinct mGFR trajectory classes were identified.
  • Three classes showed slow linear mGFR decline; two classes exhibited high baseline mGFR with either nonlinear decline (11 patients) or nonlinear improvement (94 patients).
  • Elevated proteinuria and blood pressure at baseline were associated with severely decreased or rapidly declining mGFR trajectories. Similar patterns were observed when using eGFR.

Conclusions:

  • LCMM successfully identified five clinically relevant subgroups of renal function trajectories in the CKD cohort.
  • This methodology can be applied to other CKD cohorts for enhanced characterization of disease progression profiles.
  • LCMM facilitates the investigation of specific risk factors linked to distinct CKD progression patterns.